SCHEMBL23799231

SCHEMBL23799231

CNC1CCN(C2CCC(C#N)(c3ccc(F)cn3)CC2)C1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.41
ROCK2 O75116 1/20 0.34
ROCK1 Q13464 1/20 0.34
CDC42BPB Q9Y5S2 1/20 0.34
ACKR3 P25106 4/20 0.34
IRAK4 Q9NWZ3 3/20 0.33
FGFR1 P11362 1/20 0.33
FGFR2 P21802 1/20 0.33
FGFR4 P22455 1/20 0.33
FGFR3 P22607 1/20 0.33
KDM1A O60341 1/20 0.32
SLC6A5 Q9Y345 1/20 0.32
HRH4 Q9H3N8 1/20 0.31
CCR2 P41597 2/20 0.31
HRH2 P25021 1/20 0.30
HRH1 P35367 1/20 0.30
HRH3 Q9Y5N1 1/20 0.30
FFAR4 Q5NUL3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23798647 0.87 USP30 (0.34) CYP2D6IRAK4KDM1ASLC6A5HRH4
SCHEMBL23778306 0.86 CYP2D6 (0.44) CYP2D6ACKR3SLC6A5CCR2FFAR4
SCHEMBL23799160 0.83 CYP2D6 (0.56) CYP2D6KDM1ASLC6A5
SCHEMBL23798649 0.83 CCR2 (0.41) CYP2D6IRAK4KDM1ACCR2HRH3
SCHEMBL20074569 0.82 CYP2D6 (0.40) CYP2D6ACKR3SLC6A5CCR2HRH3
SCHEMBL23798594 0.77 CYP2D6 (0.35) CYP2D6IRAK4KDM1AHRH4CCR2
SCHEMBL23798687 0.77 CYP2D6 (0.48) CYP2D6KDM1ACCR2
SCHEMBL23798665 0.76 CYP2D6 (0.53) CYP2D6KDM1A
SCHEMBL23778248 0.76 CYP2D6 (0.43) CYP2D6ACKR3HRH3FFAR4
SCHEMBL11920963 0.75 FFAR4 (0.35) FGFR1FGFR2FGFR4FGFR3FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3526207-B1 HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. HEPTARES THERAPEUTICS LTD (GB) 2021-09-08 EP disclosed